Health Care Sector Stocks Technical Data -- Research on Bacterin International Holdings, Align Technology, Endologix, and Unilife Editor Note: For more information about this release, please scroll to bottom.
LONDON, May 12, 2014 /PRNewswire/ --
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the session at 16,583.34, up 0.20% and the S&P 500 closed at 1,878.48, up 0.15%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has gained 3.66% in the previous one month. Investor-Edge has initiated coverage on the following equities: Bacterin International Holdings Inc. (NYSE MKT: BONE), Align Technology Inc. (NASDAQ: ALGN), Endologix Inc. (NASDAQ: ELGX) and Unilife Corp. (NASDAQ: UNIS). Free technical research on BONE, ALGN, ELGX and UNIS can be downloaded upon signing up at:
On Friday, shares in Bacterin International Holdings Inc. edged 0.62% higher on Friday, closing the day at $0.71. The stock recorded a trading volume of 0.23 million shares, which was below its three months average volume of 0.47 million shares. The stock oscillated between $0.70 and $0.72 during the session. Over the last one month and from the beginning of 2014, Bacterin International Holdings Inc.'s shares have surged 12.70% and 42.00%, respectively. However, the stock has declined 6.58% in the previous three trading sessions. The company's shares are trading below their 50-day moving average. Bacterin International Holdings Inc.'s 50-day moving average of $0.74 is above its 200-day moving average of $0.61. Further, the company's stock has a Relative Strength Index (RSI) of 48.53. Sign up today to read free research on BONE at:
On Friday, shares in Align Technology Inc. recorded a trading volume of 0.65 million shares, which was below its three months average volume of 0.95 million shares. The stock ended the day at $49.45, which was 2.94% higher its previous day's closing of $48.04, and registered an intraday range of $47.52 and $49.46. Align Technology Inc.'s stock has advanced 0.86% in the previous three trading sessions and 0.12% in the last one month, while it has lost 13.46% on YTD basis. The company's shares are trading below their 50-day and 200-day moving averages of $52.21 and $52.06, respectively. Furthermore, shares of the company traded at a PE ratio of 29.43 and have an RSI of 44.05. Sign up today to read free research on ALGN at:
Endologix Inc.'s stock fluctuated between $12.76 and $13.14 before ending the session 0.62% higher at $13.00. On Friday, the company's stock reported a trading volume of 1.26 million shares, above its three months average volume of 0.93 million shares. Over the previous three trading sessions and on YTD basis, shares in Endologix Inc. have lost 2.18% and 25.46%, respectively. However, the stock has advanced 7.53% in the last one month. The company's shares are trading above their 50-day moving average. Endologix Inc.'s 50-day moving average of $12.98 is below its 200-day moving average of $15.80. Moreover, the company's stock has an RSI of 51.31. Sign up today to read free research on ELGX at:
Shares in Unilife Corp. finished Friday's trading session 7.00% higher at $3.21. A total of 0.75 million shares were traded, which was below its three months average volume of 1.31 million shares. The stock moved between $2.95 and $3.26 during the session. Unilife Corp.'s stock has advanced 1.90% in the previous three trading sessions, while it has fallen by 5.87% in the last one month and 27.05% since the start of this year. The company's shares are trading below their 50-day and 200-day moving averages of $3.96 and $3.75, respectively. Additionally, the company's stock has an RSI of 42.67. Sign up today to read free research on UNIS at:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.